INKON Life Technology Co Ltd operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares INKON Life Technology Co Ltd with three other
pharmaceutical manufacturers in Asia:
Medical & Biological Laboratories Company Limited
sales of 7.07 billion Japanese Yen [US$64.21 million]
of which 99%
was Reagent business),
(1.73 billion Taiwanese Dollars [US$57.71 million]
of which 52%
was Sale of Precision Medical Equipment), and
Hang Tai Yue Group Holdings Ltd
based in Hong Kong
(471.48 million Hong Kong Dollars [US$60.69 million]
of which 77%
was Mobile Internet Cultural Business).
INKON Life Technology Co Ltd reported sales of 504.02 million Chinese Renmimbi (US$73.40 million)
December of 2018.
increase of 53.1%
versus 2017, when the company's sales were 329.23 million Chinese Renmimbi.
Sales of Other Operatings saw an increase
that was more than double the company's growth rate: sales were up
114.7% in 2018, from
10.59 million Chinese Renmimbi to 22.75 million Chinese Renmimbi.
INKON Life Technology Co Ltd also saw significant increases in sales in
Medical Services Division (up 110.6% to 395.80 million Chinese Renmimbi)
Not all segments of INKON Life Technology Co Ltd experienced an increase in sales in 2018:
sales of Medical Equipment Division fell 34.6% to 85.47 million Chinese Renmimbi.